Childhood leukaemia: long-term excess mortality and the proportion 'cured'

被引:18
作者
Shah, A. [1 ]
Stiller, C. A. [2 ]
Kenward, M. G. [1 ]
Vincent, T. [2 ]
Eden, T. O. B. [3 ]
Coleman, M. P. [1 ]
机构
[1] London Sch Hyg & Trop Med, Non Communicable Dis Epidemiol Unit, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England
[2] Univ Oxford, Dept Paediat, Childhood Canc Res Grp, Oxford OX2 6HJ, England
[3] Christie Hosp NHS Trust, Teenage Canc Trust Young Oncol Unit, Acad Unit Paediat & Adolescent Oncol, Manchester M20 4BX, Lancs, England
关键词
survival; cure; childhood leukaemia; trends;
D O I
10.1038/sj.bjc.6604466
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Survival from childhood leukaemia has increased, but the proportion of children cured is unknown. The proportion 'cured' is defined as the proportion of survivors for whom, as a group, there is no longer excess mortality compared to the general population. Average time to cure is defined as the time since diagnosis at which the excess mortality rate has declined to or below a predetermined small value. Data on children diagnosed with leukaemia during 1971-2000 in Great Britain were used to estimate trends in survival, the proportion cured and the average time to cure. Five-year survival for all types of leukaemia combined rose from 33 to 79% by 2000. The percentage cured rose from 25 to 68% by 1995; it is predicted to increase to 73% for those diagnosed more recently. Average time to cure increased from 12 years (95% confidence interval (CI): 11-14) to 19 years (95% CI: 14-26) for lymphoid leukaemia (average annual increase of 0.3 years; P<0.001), but remained at about 5 years for acute nonlymphoblastic leukaemia. The proportion of children cured of leukaemia has risen dramatically, but the period of excess mortality associated with lymphoid leukaemia has also increased, possibly because of late relapse, secondary malignancy and toxicity from treatment.
引用
收藏
页码:219 / 223
页数:5
相关论文
共 35 条
[1]   Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983 [J].
Bhatia, S ;
Sather, HN ;
Pabustan, OB ;
Trigg, ME ;
Gaynon, PS ;
Robison, LL .
BLOOD, 2002, 99 (12) :4257-4264
[2]   Deriving more up-to-date estimates of long-term patient survival [J].
Brenner, H ;
Gefeller, O .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (02) :211-216
[3]   Long-term cause-specific mortality among five-year survivors of childhood cancer [J].
Cardous-Ubbink, MC ;
Heinen, RC ;
Langeveld, NE ;
Bakker, PJM ;
Voûte, PA ;
Caron, HN ;
van Leeuwen, FE .
PEDIATRIC BLOOD & CANCER, 2004, 42 (07) :563-573
[4]  
COLEMAN MP, 1999, SERIES SMPS, V61, P588
[5]   Second malignancies in patients treated for childhood acute lymphoblastic leukemia [J].
Dalton, VMK ;
Gelber, RD ;
Li, F ;
Donnelly, MJ ;
Tarbell, NJ ;
Sallan, SE .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2848-2853
[6]  
De Angelis R, 1999, STAT MED, V18, P441, DOI 10.1002/(SICI)1097-0258(19990228)18:4<441::AID-SIM23>3.3.CO
[7]  
2-D
[8]   Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997 [J].
Eden, OB ;
Harrison, G ;
Richards, S ;
Lilleyman, JS ;
Bailey, CC ;
Chessells, JM ;
Hann, IM ;
Hill, FGH ;
Gibson, BES .
LEUKEMIA, 2000, 14 (12) :2307-2320
[9]  
Esteve J, 1994, IARC SCI PUBLICATION, V128
[10]   Survival following relapse in childhood haematological malignancies diagnosed in 1974-2003 in Yorkshire, UK [J].
Feltbower, R. G. ;
Kinsey, S. E. ;
Richards, M. ;
Shenton, G. ;
Michelagnoli, M. P. ;
McKinney, P. A. .
BRITISH JOURNAL OF CANCER, 2007, 96 (07) :1147-1152